Company intelligence / Profile preview
Beijing Dongfang Baitai Biotechnology Co., Ltd.
Beijing, Beijing, Chinaen.east-bt.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company’s lead product Tai Xin Sheng® (nimotuzumab) was the first humanized monoclonal antibody targeting nasopharyngeal carcinoma approved in China. It has been included in the Chinese Pharmacopoeia since 2015 and national medical insurance since 2017. The company maintains a broad pipeline of innovative biologics targeting oncology and chronic disease indications with over twenty R&D programs.[1][2][3][5][6][7]
- Therapeutic areas
- OncologyPulmonologyEndocrinologyImmunologyOtherOphthalmology
- Modalities
- Monoclonal antibodies (mAbs)Humanized monoclonal antibodiesBispecific antibodiesAntibody fusion proteinsTherapeutic vaccines
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
No major international pharma partnerships disclosed publicly as of July 2024.Recognized by municipal authorities as a foreign-funded/global R&D center.
Beyond the preview
Go deeper on Beijing Dongfang Baitai Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Dongfang Baitai Biotechnology Co., Ltd..